28 related articles for article (PubMed ID: 21192345)
1. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.
Tavares LC; Duarte NE; Marcatto LR; Soares RAG; Krieger JE; Pereira AC; Santos PCJL
Eur J Clin Pharmacol; 2018 Dec; 74(12):1555-1566. PubMed ID: 30051215
[TBL] [Abstract][Full Text] [Related]
2. Warfarin Dose Model for the Prediction of Stable Maintenance Dose in Indian Patients.
Gaikwad T; Ghosh K; Avery P; Kamali F; Shetty S
Clin Appl Thromb Hemost; 2018 Mar; 24(2):353-359. PubMed ID: 28049362
[TBL] [Abstract][Full Text] [Related]
3. Influence of two common polymorphisms in the EPHX1 gene on warfarin maintenance dosage: a meta-analysis.
Liu HQ; Zhang CP; Zhang CZ; Liu XC; Liu ZJ
Biomed Res Int; 2015; 2015():564149. PubMed ID: 25629049
[TBL] [Abstract][Full Text] [Related]
4. Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.
Krishna Kumar D; Shewade DG; Loriot MA; Beaune P; Balachander J; Sai Chandran BV; Adithan C
Eur J Clin Pharmacol; 2014 Jan; 70(1):47-56. PubMed ID: 24019055
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population.
Kumar DK; Shewade DG; Surendiran A; Adithan C
J Pharmacol Pharmacother; 2013 Jan; 4(1):53-8. PubMed ID: 23662025
[TBL] [Abstract][Full Text] [Related]
6. Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.
Shen HC; Hammock BD
J Med Chem; 2012 Mar; 55(5):1789-808. PubMed ID: 22168898
[No Abstract] [Full Text] [Related]
7. The pharmacogenetics of the response to warfarin in Chinese.
Lam MP; Cheung BM
Br J Clin Pharmacol; 2012 Mar; 73(3):340-7. PubMed ID: 22023024
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.
Hu G; Shi Z; Hu J; Zou G; Peng G; Ran P
Respirology; 2008 Nov; 13(6):837-50. PubMed ID: 18811882
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms with warfarin dose requirements in Chinese patients.
Liang Y; Chen Z; Guo G; Dong X; Wu C; Li H; Wang T; Xu B
Genet Test Mol Biomarkers; 2013 Dec; 17(12):932-6. PubMed ID: 23941071
[TBL] [Abstract][Full Text] [Related]
10. Exon sequencing and association analysis of EPHX1 genetic variants with maintenance warfarin dose in a multiethnic Asian population.
Chan SL; Thalamuthu A; Goh BC; Chia KS; Chuah B; Wong A; Lee SC
Pharmacogenet Genomics; 2011 Jan; 21(1):35-41. PubMed ID: 21192345
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.
Issac MS; El-Nahid MS; Wissa MY
Mol Diagn Ther; 2014 Feb; 18(1):73-83. PubMed ID: 24092646
[TBL] [Abstract][Full Text] [Related]
12. Effects of
Lin X; Chen H; Ni L; Yu Y; Luo Z; Liao L
Pharmacogenomics; 2020 Aug; 21(12):863-870. PubMed ID: 32559398
[No Abstract] [Full Text] [Related]
13. Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses.
Chung JE; Lee KE; Chang BC; Gwak HS
Gene; 2018 Jan; 641():68-73. PubMed ID: 29054760
[TBL] [Abstract][Full Text] [Related]
14. [Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population].
Lou Y; Han L; Li Y; Zhang X; Liu Z; Tang M; Yu H; Wang W; Xu J; Liu H; Li Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):367-71. PubMed ID: 24928022
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
